TiGenix NV (Nasdaq:TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering.
TiGenix NV (Nasdaq:TIG), an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering.